4
Changes in Ownership
Entrada Therapeutics, Inc. Filed Acc 0001689375-23-000056
President and CEO sold 1,000 shares at $15.67 ($15,671)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Doshi Dipal President and CEO | 2023-08-14 | Sale 10b5-1 | −1,000 | $15.67 | $15,671 | 201,069 | D: show line 1 in the form |
| Open-market sales · 1,000 sh · avg $15.67 · $15,671 | |||||||
Loading xslF345X05/wf-form4_169221794370631.xml…